Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022

SELL
$16.06 - $26.39 $5.93 Million - $9.74 Million
-369,165 Reduced 38.87%
580,533 $9.88 Million
Q2 2022

Jul 22, 2022

SELL
$20.49 - $39.72 $7.66 Million - $14.9 Million
-374,075 Reduced 28.26%
949,698 $20.4 Million
Q1 2022

Apr 25, 2022

BUY
$28.19 - $46.6 $1.44 Million - $2.38 Million
51,000 Added 4.01%
1,323,773 $49 Million
Q4 2021

Jan 21, 2022

BUY
$41.2 - $73.6 $9.91 Million - $17.7 Million
240,415 Added 23.29%
1,272,773 $57.9 Million
Q3 2021

Oct 22, 2021

BUY
$59.15 - $91.99 $40.5 Million - $62.9 Million
684,171 Added 196.5%
1,032,358 $65.4 Million
Q2 2021

Jul 27, 2021

BUY
$63.02 - $95.11 $21.9 Million - $33.1 Million
348,187 New
348,187 $31.9 Million
Q1 2021

Apr 23, 2021

SELL
$57.62 - $95.6 $1.57 Million - $2.6 Million
-27,225 Closed
0 $0
Q4 2020

Jan 26, 2021

SELL
$41.43 - $77.09 $867,129 - $1.61 Million
-20,930 Reduced 43.46%
27,225 $1.97 Million
Q3 2020

Oct 23, 2020

BUY
$30.88 - $37.94 $81,832 - $100,541
2,650 Added 5.82%
48,155 $1.83 Million
Q2 2020

Aug 03, 2020

BUY
$18.95 - $35.43 $363,840 - $680,256
19,200 Added 72.99%
45,505 $1.61 Million
Q1 2020

Apr 17, 2020

SELL
$13.94 - $28.25 $98,974 - $200,575
-7,100 Reduced 21.25%
26,305 $574,000
Q4 2019

Jan 24, 2020

BUY
$19.24 - $28.41 $354,016 - $522,744
18,400 Added 122.63%
33,405 $721,000
Q3 2019

Oct 25, 2019

BUY
$20.03 - $40.08 $78,117 - $156,312
3,900 Added 35.12%
15,005 $339,000
Q2 2019

Aug 02, 2019

SELL
$25.78 - $39.77 $51,302 - $79,142
-1,990 Reduced 15.2%
11,105 $400,000
Q1 2019

Apr 18, 2019

BUY
$22.09 - $39.21 $289,268 - $513,454
13,095 New
13,095 $413,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.